Innovations in Cutaneous Lupus
Authors:
- 14 September 2024
- journal article
- research article
- Published by Elsevier in Dermatologic Clinics
- Vol. 43 (1) , 123-136
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Anifrolumab for Adolescent Discoid Lupus ErythematosusJAMA Network Open, 2023
- Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus ErythematosusJAMA Dermatology, 2023
- Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJAMA Dermatology, 2020
- Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus ErythematosusJAMA Dermatology, 2018
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled StudyArthritis & Rheumatology, 2017
- Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus ErythematosusArthritis Care & Research, 2016
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled TrialsArthritis & Rheumatology, 2016
- Brief Report: Responses to Rituximab Suggest B Cell–Independent Inflammation in Cutaneous Systemic Lupus ErythematosusArthritis & Rheumatology, 2015
- Incidence of Cutaneous Lupus Erythematosus, 1965-2005Archives of Dermatology, 2009
- Frequency and Severity of Systemic Disease in Patients With Subacute Cutaneous Lupus ErythematosusArchives of Dermatology, 2002